SARS-CoV-2感染、COVID-19与择期手术时机:多学科共识声明
该多学科共识声明基于系统综述证据与专家意见,提出SARS-CoV-2感染后择期手术时机的关键原则。声明建议除非推迟手术风险超过COVID-19相关术后并发症或死亡风险,否则不应在确诊SARS-CoV-2感染后7周内安排择期手术。多数患者为短暂或无症状疾病,除7周延迟外无需额外防护,但持续症状或住院患者需特别关注。
要点
- 择期手术不应在SARS-CoV-2感染确诊后7周内安排,除非推迟手术的风险更高
- 手术时机决策需考虑初始感染严重程度、持续症状、合并症与功能状态、临床优先级及手术复杂性
- 持续COVID-19症状患者即使超过7周,术后并发症和死亡风险仍增加
核心结论
- 择期手术不应在SARS-CoV-2感染确诊后7周内安排,除非推迟手术的风险超过COVID-19相关术后并发症或死亡风险。
- 多数SARS-CoV-2感染者表现为短暂或无症状疾病,除7周延迟外无需额外防护,但持续症状或住院患者需特别关注。
- 持续COVID-19症状患者即使超过7周,术后并发症和死亡风险仍增加。
研究设计与样本
- 该共识声明由麻醉医师协会、围术期护理中心、外科专科协会联合会、皇家麻醉医师学院和英格兰皇家外科医师学院共同制定,基于系统综述证据与专家意见。
主要发现
- 择期手术不应在SARS-CoV-2感染确诊后7周内安排,除非推迟手术的风险超过COVID-19相关术后并发症或死亡风险。
- 持续COVID-19症状患者即使超过7周,术后并发症和死亡风险仍增加。
- 多数患者为短暂或无症状疾病,除7周延迟外无需额外防护,但持续症状或住院患者需特别关注。
关键数值与推荐
- 择期手术不应在SARS-CoV-2感染确诊后7周内安排,除非推迟手术的风险超过COVID-19相关术后并发症或死亡风险。
- 手术时机决策需考虑初始感染严重程度、持续COVID-19症状、合并症与功能状态、临床优先级与疾病进展风险以及手术复杂性。
- 为保护工作人员、其他患者和公众,在患者可能具有传染性的期间不应考虑计划手术。
- 应采取预防措施防止术前和围术期感染,尤其对高风险患者。
- 手术前数周接种疫苗将降低患者风险,并可能减少其他患者和工作人员院内SARS-CoV-2感染风险。
临床怎么用
- 择期手术前应评估SARS-CoV-2感染史,确诊感染后7周内原则上推迟手术,除非推迟风险更高。
- 手术时机决策应采用共享决策,综合考虑感染严重程度、持续症状、合并症与功能状态、临床优先级及手术复杂性。
- 利用手术前时间进行功能评估、预康复和多学科优化。
- 持续症状或曾住院患者需特别关注,即使超过7周仍应评估术后并发症和死亡风险。
- 建议手术前数周接种疫苗,国家疫苗委员会应考虑此类患者优先接种。
局限性
- 随着更多数据出现,这些建议可能需要修订。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The scale of the COVID-19 pandemic means that a significant number of patients who have previously been infected with SARS-CoV-2 will require surgery. Given the potential for multisystem involvement, timing of surgery needs to be carefully considered to plan for safe surgery. This consensus statement uses evidence from a systematic review and expert opinion to highlight key principles in the timing of surgery. Shared decision-making regarding timing of surgery after SARS-CoV-2 infection must account for severity of the initial infection; ongoing symptoms of COVID-19; comorbid and functional status; clinical priority and risk of disease progression; and complexity of surgery. For the protection of staff, other patients and the public, planned surgery should not be considered during the period that a patient may be infectious. Precautions should be undertaken to prevent pre- and peri-operative infection, especially in higher risk patients. Elective surgery should not be scheduled within 7 weeks of a diagnosis of SARS-CoV-2 infection unless the risks of deferring surgery outweigh the risk of postoperative morbidity or mortality associated with COVID-19. SARS-CoV-2 causes either transient or asymptomatic disease for most patients, who require no additional precautions beyond a 7-week delay, but those who have persistent symptoms or have been hospitalised require special attention. Patients with persistent symptoms of COVID-19 are at increased risk of postoperative morbidity and mortality even after 7 weeks. The time before surgery should be used for functional assessment, prehabilitation and multidisciplinary optimisation. Vaccination several weeks before surgery will reduce risk to patients and might lessen the risk of nosocomial SARS-CoV-2 infection of other patients and staff. National vaccine committees should consider whether such patients can be prioritised for vaccination. As further data emerge, these recommendations may need to be revised, but the principles presented should be considered to ensure safety of patients, the public and staff.
引用
- El-Boghdadly K, Cook TM, Goodacre T, et al. SARS-CoV-2 infection, COVID-19 and timing of elective surgery: A multidisciplinary consensus statement on behalf of the Association of Anaesthetists, the Centre for Peri-operative Care, the Federation of Surgical Specialty Associations, the Royal College of Anaesthetists and the Royal College of Surgeons of England. Anaesthesia. 2021. PMID: 33735942. doi:10.1111/anae.15464
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。